Open AccessEfficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial
Author(s) -
Javier Fernando Casiraghi,
Daniel E Grigera,
J. Alejo Peyret,
Melina Sol del Papa,
María Silvia Passerini
Publication year - 2021
Publication title -
re gen open
Language(s) - English
Resource type - Journals
ISSN - 2766-2705
DOI - 10.1089/regen.2021.0018
Subject(s) - latanoprost , medicine , tolerability , ophthalmology , benzalkonium chloride , intraocular pressure , glaucoma , open angle glaucoma , confidence interval , adverse effect , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom